Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Fool women twice? Drug makers revive menopause as a “disease.”

Martha Rosenberg
Conditions
March 8, 2023
53 Shares
Share
Tweet
Share

In the words of the late soccer great Pelé spoofed on Saturday Night Live, women’s health has been “very, very good” for drug makers. In 2002, 61 million prescriptions were written for women in the U.S. for hormones to treat the so-called “disease” of menopause (which was once treated with electroshock therapy—yes, ECT).

Until the government-sponsored Women’s Health Initiative (WHI) found in 2002 that hormone replacement therapy (HRT) increased the risk of breast cancer by 26 percent, heart attacks by 29 percent, stroke by 41 percent, and doubled the risk of blood clots, HRT was a rite of passage for U.S. women like getting their first bra or using Tampax. It also doubled the risk of dementia, increased the risks of losing their hearing, gallbladder disease, urinary incontinence, asthma, melanoma, ovarian, endometrial, lung cancers, and non-Hodgkin’s lymphoma.

HRT even made detecting breast cancer more difficult. A 1995 article in the journal Radiology said, “an increase in mammographic density” was demonstrated in most subjects undergoing continuous combined HRT. The therapy was such a scourge when millions of women quit the drugs en masse in 2003, the occurrence of breast cancer fell seven percent in the U.S. and 15 percent in estrogen-feed tumors.

HRT harm was also tenacious. A 2019 WHI follow-up found that “breast cancer risk from menopause hormones may last decades” and that 19 years after using HRT, women still had a 29 percent greater incidence of breast cancer.

A menopause-as-disease revival

Now, menopause as a treatable disease is back. In February, The New York Times published a sniveling personal essay about the heartbreak of “perimenopause”—a term believed to be invented by drug makers to grow sales like “osteopenia” was coined for pre-osteoporosis to sell bone drugs.

Doctors are failing to treat the condition, wrote the New York Times’ menstrual diarist, which “suggests that we have a high cultural tolerance for women’s suffering. It’s not regarded as important.” What? The breast cancer, heart attacks, stroke, blood clots, and ovarian, endometrial, and lung cancers caused by HRT were not “suffering”? Read your medical history, diarist.

Of course, drug makers desire wide swaths of the population to take their drugs for as many years as possible (think statins and GERD medicines), which explains the menopause-as-disease revival. Pharma no doubts believes women have forgotten the HRT scourge, and they are probably right!

For example, who remembers another sniveling piece published by the New York Times Sunday magazine called “The Estrogen Dilemma” more than a decade ago? The pro-HRT article quoted five HRT “experts” who all had financial links to hormone drug makers—Claudio Soares, Louann Brizendine, Roberta Diaz Brinton, Thomas Clarkson, and Sanjay Asthana. Several letters to the Times requesting a clarification went unheeded, and the disinformation stands.

A new and lucrative “disease”

Lest anyone doubt that menopause as a disease is under revival, the drug company Astellas just received a new drug application for fezolinetant, a drug to treat “VMS,” and is launching an aggressive awareness/demand building campaign about the “disease.”

What is VMS? It is “vasomotor symptoms, due to menopause,” says the marketing campaign, that “impact many aspects of your life including your sleep, ability to focus, and personal relationships,” and torture you as “your internal infernos.”

“VMS can start as early as age 40 and can last longer than ten years for some women.” (Ka-ching.)

As I have written as a reporter for years, there is money for drug makers to convince healthy people they are sick, so they will go to the doctor and request an advertised product. More money, apparently, than there is in developing drugs for people who are really sick, which should be the mission of medicine. Convincing healthy women they are sick with “perimenopause” or “menopause” is simply the latest example of disease mongering and spreading hypochondria—both for money.

Martha Rosenberg is a health reporter and the author of Born With a Junk Food Deficiency.  

Prev

Transforming health care with AI: Google Bard and BioGPT lead the way

March 8, 2023 Kevin 1
…
Next

Gratitude takes practice. How come health care workers aren’t better at it?

March 8, 2023 Kevin 0
…

Tagged as: OB/GYN

Post navigation

< Previous Post
Transforming health care with AI: Google Bard and BioGPT lead the way
Next Post >
Gratitude takes practice. How come health care workers aren’t better at it?

More by Martha Rosenberg

  • A job behind bars

    Martha Rosenberg
  • The scientific race to defeat a deadly virus

    Martha Rosenberg
  • A gun message for woke corporations

    Martha Rosenberg

Related Posts

  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • When breast cancer screening guidelines conflict: Some patients face real consequences

    Leda Dederich
  • Is social media a friend or foe of science?

    Michael Joyce, MD
  • Timely treatment decisions: the promise of surrogate markers

    Layla Parast, PhD
  • Cancer care costs everyone too much. What can we do about it?

    Andrew Hertler, MD
  • Cancer of the future: diagnosis, treatment, and impact on the health care system and patients

    Eugene Chan, MD

More in Conditions

  • The psychoanalytic hammer: lessons in listening and patient-centered care

    Greg Smith, MD
  • 5 essential tips to help men prevent prostate cancer

    Kevin Jones, MD
  • Changing the pediatric care landscape: Integrating behavioral and mental health care

    Hilary M. Bowers, MD
  • Unlocking the secret to successful weight loss: Curiosity is the key

    Franchell Hamilton, MD
  • The teacher who changed my life through reading

    Raymond Abbott
  • Revaluating mental health assessments: It’s not just the patient you should consider

    Tomi Mitchell, MD
  • Most Popular

  • Past Week

    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • From physician to patient: one doctor’s journey to finding purpose after a devastating injury

      Stephanie Pearson, MD | Physician
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
    • What I think it means to be a medical student in the wake of AI

      Jackson J. McCue | Tech
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • From rural communities to underserved populations: How telemedicine is bridging health care gaps

      Harvey Castro, MD, MBA | Physician
    • 5 essential tips to help men prevent prostate cancer

      Kevin Jones, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Sam Neill's Rare Lymphoma
  • Day in the Life of a Doctor: Treating a Patient With Septic Shock
  • Paxlovid May Lower Long COVID Risk, VA Study Suggests
  • Digital Inhalers May Improve Uncontrolled Asthma Management
  • Another Win for Zolbetuximab in Advanced Gastric/GEJ Cancer

Meeting Coverage

  • Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis
  • Biomarkers of Response With Enfortumab Vedotin in Advanced Urothelial Cancer
  • At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks
  • Outlook for Itchy Prurigo Nodularis Continues to Improve With IL-31 Antagonist
  • AAAAI President Shares Highlights From the 2023 Meeting
  • Most Popular

  • Past Week

    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • From physician to patient: one doctor’s journey to finding purpose after a devastating injury

      Stephanie Pearson, MD | Physician
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
    • What I think it means to be a medical student in the wake of AI

      Jackson J. McCue | Tech
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • From rural communities to underserved populations: How telemedicine is bridging health care gaps

      Harvey Castro, MD, MBA | Physician
    • 5 essential tips to help men prevent prostate cancer

      Kevin Jones, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...